Irinotecan monotherapy as second-line treatment in advanced pancreatic cancer

被引：0
|
作者：
Seong Yoon Yi
Young Suk Park
Hyo Song Kim
Hyun Jung Jun
Kyoung Ha Kim
Myung Hee Chang
Min Jae Park
Ji Eun Uhm
Jeeyun Lee
Se Hoon Park
Joon Oh Park
Jong Kyun Lee
Kyu Taek Lee
Ho Yeong Lim
Won Ki Kang
机构：
[1] Sungkyunkwan University School of Medicine,Division of Hematology
[2] Sungkyunkwan University School of Medicine,Oncology, Department of Medicine, Samsung Medical Center
来源：
Cancer Chemotherapy and Pharmacology | 2009年 / 63卷
关键词：
Pancreatic cancer; Irinotecan; Second line chemotherapy; Gemcitabine failure;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1141 / 1145
页数：4
相关论文
共 50 条
  • [21] A pilot study of Irinotecan plus raltitrexed as second-line treatment for advanced colorectal cancer.
    Qu, Xiujuan
    Wu, Zhenhai
    Wang, Shuo
    Qu, Jinglei
    Zhang, Lingyun
    Liu, Jing
    Shi, Jing
    Zhang, Jingdong
    Liu, Yunpeng
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [22] A phase II trial of erlotinib monotherapy in advanced pancreatic cancer as a first- or second-line agent
    Fountzilas, Christos
    Chhatrala, Ravi
    Khushalani, Nikhil
    Tan, Wei
    LeVea, Charles
    Hutson, Alan
    Tucker, Chris
    Ma, Wen Wee
    Warren, Graham
    Boland, Patrick
    Iyer, Renuka
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 80 (03) : 497 - 505
  • [23] A phase II trial of erlotinib monotherapy in advanced pancreatic cancer as a first- or second-line agent
    Christos Fountzilas
    Ravi Chhatrala
    Nikhil Khushalani
    Wei Tan
    Charles LeVea
    Alan Hutson
    Chris Tucker
    Wen Wee Ma
    Graham Warren
    Patrick Boland
    Renuka Iyer
    Cancer Chemotherapy and Pharmacology, 2017, 80 : 497 - 505
  • [24] Second-line chemotherapy with irinotecan plus cisplatin after the failure of S-1 monotherapy for advanced gastric cancer
    Takahari, Daisuke
    Shimada, Yasuhiro
    Takeshita, Shigeyuki
    Nishitani, Hitoshi
    Takashima, Atsuo
    Okita, Natsuko
    Hirashima, Yoshinori
    Kato, Ken
    Hamaguchi, Tetsuya
    Yamada, Yasuhide
    Shirao, Kuniaki
    GASTRIC CANCER, 2010, 13 (03) : 186 - 190
  • [25] Second-line chemotherapy with irinotecan plus cisplatin after the failure of S-1 monotherapy for advanced gastric cancer
    Daisuke Takahari
    Yasuhiro Shimada
    Shigeyuki Takeshita
    Hitoshi Nishitani
    Atsuo Takashima
    Natsuko Okita
    Yoshinori Hirashima
    Ken Kato
    Tetsuya Hamaguchi
    Yasuhide Yamada
    Kuniaki Shirao
    Gastric Cancer, 2010, 13 : 186 - 190
  • [26] A preclinical evaluation of pemetrexed and irinotecan combination as second-line chemotherapy in pancreatic cancer
    A Mercalli
    V Sordi
    R Formicola
    M Dandrea
    S Beghelli
    A Scarpa
    V Di Carlo
    M Reni
    L Piemonti
    British Journal of Cancer, 2007, 96 : 1358 - 1367
  • [27] A preclinical evaluation of pemetrexed and irinotecan combination as second-line chemotherapy in pancreatic cancer
    Mercalli, A.
    Sordi, V.
    Formicola, R.
    Dandrea, M.
    Beghelli, S.
    Scarpa, A.
    Di Carlo, V.
    Reni, M.
    Piemonti, L.
    BRITISH JOURNAL OF CANCER, 2007, 96 (09) : 1358 - 1367
  • [28] Second-Line Treatment for Advanced Pancreatic Adenocarcinoma: Is There a Role for Gemcitabine?
    Girardi, Daniel M.
    Faria, Luiza Dib B. B.
    Teixeira, Marcela C.
    Costa, Frederico P.
    Hoff, Paulo Marcelo G.
    Fernandes, Gustavo S.
    JOURNAL OF GASTROINTESTINAL CANCER, 2019, 50 (04) : 860 - 866
  • [29] Second-Line Treatment for Advanced Pancreatic Adenocarcinoma: Is There a Role for Gemcitabine?
    Daniel M. Girardi
    Luiza Dib B. B. Faria
    Marcela C. Teixeira
    Frederico P. Costa
    Paulo Marcelo G. Hoff
    Gustavo S. Fernandes
    Journal of Gastrointestinal Cancer, 2019, 50 : 860 - 866
  • [30] Beneficial trends of second-line chemotherapy in advanced pancreatic cancer
    Silva, Milton Jose B.
    Maia, Joyce Maria L.
    Ribeiro, Adriana Regina G.
    Chinen, Ludmilla T. D.
    Paiva, Tadeu Ferreira, Jr.
    Padua, Fernando Vidigal
    Ismael Pinto, Flavio Augusto
    Santos, Elizabeth Santana
    Mello, Celso Lopes
    Campanha, Daniel
    Rodrigues Pereira, Augusto Akikubo
    Fanelli, Marcello Ferretti
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
12345